Article Name Predictive Diagnostics
AIxMed's AIxURO solution is specifically developed to assist in the analysis of non-invasive urine cytology specimens
04th November, 2025
The successful filing of the XJ LLM represents a milestone in Fangzhou’s AI-enabled chronic disease management ecosystem
03rd November, 2025
Dosimetry portfolio strengthened with Medical Imaging QA and AI validation
03rd November, 2025
The new findings show that patients can safely have additional arteries treated immediately during the first procedure to treat the acute event
31st October, 2025
The 52-week data from these two Phase III clinical trials demonstrate the durability of response and highlight the comprehensive long-term clinical benefits of HTD1801 in patients with T2DM
31st October, 2025
Renowned pain management and medical technology leader to accelerate Glucotrack’s strategy for integrated glucose monitoring applications, building on the Company’s 2024 expansion into epidural monitoring
30th October, 2025
The genetic testing revolution has fundamentally transformed how we approach human reproduction
24th October, 2025
RetinAI develops advanced tools to collect, process and grade large-scale retinal images and biomarker datasets
16th October, 2025
Partnership will evaluate advanced ultrasound technologies to improve early detection and monitoring of Metabolically Dysfunctional-Associated Steatotic Liver Disease
08th October, 2025
The Elecsys Troponin T hs Gen 6 test offers enhanced analytical sensitivity, superior robustness, and unprecedented standardization demonstrating traceability to NIST reference materials
07th October, 2025
AiM’s breakthrough technology enables surgeons to perform precise neurosurgical procedures directly within an MRI
01st October, 2025
The self-collected option allows patients to collect their own sample in private, eliminating the need for a pelvic exam
01st October, 2025
The test helps clinicians quickly identify heart attacks and rule out non-cardiac causes, ensuring patients receive the care they need at the earliest opportunity.
30th September, 2025
The voluntary action affects devices manufactured before May 12, 2025, after reports of component detachment linked to patient injuries and one death, with Olympus reinforcing safeguards to prioritise patient safety.
23rd September, 2025
The partnership integrates Lunit’s oncology-focused AI with Agilent’s diagnostic expertise to accelerate biomarker testing, enhance drug development, and drive the next wave of precision medicine.
23rd September, 2025
The Institute, led by Dr. Shyam Sathanandam, is transforming neonatal cardiac care by delivering minimally invasive PDA closures directly in the NICU—eliminating transport risks and accelerating recovery for South Florida’s most vulnerable infants.
23rd September, 2025
Medtech firm unveils Axana®, a 50kg, AI-enhanced, portable MRI device that cuts stroke diagnosis time by over 90%—unlocking lifesaving treatment in the golden hour and opening an $8.9bn global market opportunity.
16th September, 2025
Breakthrough bioactive glass device offers surgeons a safe, resorbable, and cost-effective alternative to metal implants, engineered to accelerate bone regeneration and streamline surgical workflow.
11th September, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer